aTyr Pharma, Inc.

Mineralys Therapeutics, Inc. , which launched the largest biopharmaceutical company initial public offering so far this year late on 9 February, was an ideal IPO candidate under current market conditi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Terray Inks Initial Partnership With Ca

The number of US initial public offerings by biopharmaceutical companies in 2021 reached 87 on 14 September when DICE Therapeutics, Inc. , Tyra Biosciences, Inc. and Pasithea Therapeutics Corp. w

Vor Hopes NCI’s CAR-T Candidate Is Synergistic With Lead AML Therapy PureTech Health plc -backed Vor Biopharma Inc. said on 11 November that it has licensed a clinical-stage chimeric antigen recept